Oruka Therapeutics, Inc. (ORKA)

Oruka Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	33.28	37.43	42.45	53.36	49.07	8.36
Cash & Cash Equivalents	33.28	37.43	42.45	53.36	49.07	8.36
Cash Growth	-17.12%	-11.81%	-20.45%	8.74%	486.76%	26.56%
Other Current Assets	0.54	0.16	0.25	1.06	0.9	0.12
Total Current Assets	33.82	37.59	42.7	54.42	49.97	8.48
Property, Plant & Equipment	0.01	0.26	0.37	0.49	0.45	0.03
Other Long-Term Assets	0.01	0.01	0.02	0.02	0.01	0.02
Total Long-Term Assets	0.02	0.27	0.39	0.5	0.46	0.06
Total Assets	33.84	37.86	43.09	54.92	50.43	8.54
Accounts Payable	0.57	0.36	0.33	1.12	1.77	0.42
Other Current Liabilities	0.7	0.28	0.8	2.38	1.73	0.51
Total Current Liabilities	1.27	0.64	1.13	3.5	3.5	0.93
Long-Term Debt	0	0.2	0.28	0.38	0.41	0
Total Long-Term Liabilities	0	0.2	0.28	0.38	0.41	0
Total Liabilities	1.27	0.84	1.41	3.88	3.91	0.93
Total Debt	0	0.2	0.28	0.38	0.41	0
Debt Growth	-	-27.14%	-26.89%	-6.36%	-	-
Retained Earnings	-193.43	-188.74	-183.4	-173.48	-154.15	-144.42
Shareholders' Equity	32.57	37.02	41.67	51.04	46.52	7.61
Net Cash / Debt	33.28	37.23	42.17	52.98	48.66	8.36
Net Cash / Debt Growth	-16.61%	-11.71%	-20.41%	8.87%	481.87%	26.56%
Net Cash Per Share	27.53	30.99	35.11	45.72	123.97	75.96
Working Capital	32.55	36.96	41.57	50.92	46.47	7.55
Book Value Per Share	26.94	30.82	34.70	44.05	118.52	69.12

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).